相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Longitudinal Dynamics of the Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Kai Wang et al.
CLINICAL INFECTIOUS DISEASES (2021)
Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections
Qing Lei et al.
ALLERGY (2021)
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019
Jee-Soo Lee et al.
CLINICAL INFECTIOUS DISEASES (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
(A Little) Clarity on Convalescent Plasma for Covid-19
Louis M. Katz
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
M. J. Joyner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
V. A. Simonovich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neutralizing antibody titres in SARS-CoV-2 infections
Eric H. Y. Lau et al.
NATURE COMMUNICATIONS (2021)
Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals
Jian Zhang et al.
NATURE MICROBIOLOGY (2021)
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test
Xuping Xie et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2021)
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
Carlo Cervia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera
Kasopefoluwa Y. Oguntuyo et al.
MBIO (2021)
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
Zhenyu He et al.
LANCET (2021)
IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers
Rianna Vandergaast et al.
MSPHERE (2021)
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods
Berislav Bosnjak et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter
Wen-Yang Tsai et al.
EMERGING MICROBES & INFECTIONS (2021)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
Gregory D. Sempowski et al.
CELL (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Serological assays for severe acute respiratory syndrome coronavirus 2 (BARS-CoV-2), March 2020
Ranawaka A. P. M. Perera et al.
EUROSURVEILLANCE (2020)
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ling Ni et al.
IMMUNITY (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples
Alessandro Manenti et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
TMPRSS2 and COVID-19: serendipity or Opportunity for Intervention?
Konrad H. Stopsack et al.
CANCER DISCOVERY (2020)
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19
Wen-Hsiang Chen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Feng-Cai Zhu et al.
LANCET (2020)
Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
Gabriel Siracusano et al.
FRONTIERS IN IMMUNOLOGY (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
Christoph Kreer et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
M. Eugenia Dieterle et al.
CELL HOST & MICROBE (2020)
Replication-Competent Vesicular Stomatitis Virus Vaccine Vector Protects against SARS-CoV-2-Mediated Pathogenesis in Mice
James Brett Case et al.
CELL HOST & MICROBE (2020)
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
Jiandong Huo et al.
CELL HOST & MICROBE (2020)
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
James Brett Case et al.
CELL HOST & MICROBE (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France
Samira Fafi-Kremer et al.
EBIOMEDICINE (2020)
Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes
Ferdinand Zettl et al.
VACCINES (2020)
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting
Katherine Bond et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Coronaviruses pandemics: Can neutralizing antibodies help?
Phuoc-Bao-Viet Tong et al.
LIFE SCIENCES (2020)
COVID-19 Makes B Cells Forget, but T Cells Remember
Pablo F. Canete et al.
CELL (2020)
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
Yang Li et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Jingyun Yang et al.
NATURE (2020)
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Kizzmekia S. Corbett et al.
NATURE (2020)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani et al.
NATURE (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction
Chee Wah Tan et al.
NATURE BIOTECHNOLOGY (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Jennifer A. Juno et al.
NATURE MEDICINE (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan et al.
SCIENCE (2020)
Potential Antiviral Options against SARS-CoV-2 Infection
Aleksandr Ianevski et al.
VIRUSES-BASEL (2020)
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
Antonio E. Muruato et al.
NATURE COMMUNICATIONS (2020)
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
Tyler J. Ripperger et al.
IMMUNITY (2020)
COVID-19 and the Path to Immunity
David S. Stephens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
Larry L. Luchsinger et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2020)
Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient
Shengxia Yin et al.
JOURNAL OF INFECTION (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Neuropilin-1 is a host factor for SARS-CoV-2 infection
James L. Daly et al.
SCIENCE (2020)
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Carl A. Pierce et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
Inesa Hyseni et al.
VIRUSES-BASEL (2020)
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Dianna L. Ng et al.
NATURE COMMUNICATIONS (2020)
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
Xuping Xie et al.
NATURE COMMUNICATIONS (2020)
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients
Yuxin Chen et al.
PLOS PATHOGENS (2020)
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
Benjamin Meyer et al.
EMERGING MICROBES & INFECTIONS (2020)
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow et al.
NATURE MICROBIOLOGY (2020)
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
James R. Byrnes et al.
MSPHERE (2020)
Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR
Jing Lu et al.
EBIOMEDICINE (2020)
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
Anita S. Iyer et al.
SCIENCE IMMUNOLOGY (2020)
A simple protein-based surrogate neutralization assay for SARS-CoV-2
Kento T. Abe et al.
JCI INSIGHT (2020)
Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test
Jianghong An et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
Josee Perreault et al.
BLOOD (2020)
Convalescent plasma anti SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
Eric Salazar et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
Kening Li et al.
NATURE COMMUNICATIONS (2020)
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
Catherine J. Reynolds et al.
SCIENCE IMMUNOLOGY (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
Jie Hu et al.
GENES & DISEASES (2020)
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
David S. Khoury et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
Hua-Long Xiong et al.
EMERGING MICROBES & INFECTIONS (2020)
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Jeremie Prevost et al.
CELL REPORTS MEDICINE (2020)
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients
Nisreen M. A. Okba et al.
EMERGING INFECTIOUS DISEASES (2020)
Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
Yongzhi Xi
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Mehul S. Suthar et al.
CELL REPORTS MEDICINE (2020)
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Xiangyu Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
Jennifer Harcourt et al.
EMERGING INFECTIOUS DISEASES (2020)
Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
Guangyu Zhou et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease
Pengfei Wang et al.
EMERGING MICROBES & INFECTIONS (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
High neutralizing antibody titer in intensive care unit patients with COVID-19
Li Liu et al.
EMERGING MICROBES & INFECTIONS (2020)
Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19
Pengcheng Liu et al.
EMERGING MICROBES & INFECTIONS (2020)
Determination of neutralization activities by a new versatile assay using an HIV-1 genome carrying the Gaussia luciferase gene
Yuepeng Zhang et al.
JOURNAL OF VIROLOGICAL METHODS (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Current status on the development of pseudoviruses for enveloped viruses
Qianqian Li et al.
REVIEWS IN MEDICAL VIROLOGY (2018)
A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system
Li Zhang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits
James E. Robinson et al.
NATURE COMMUNICATIONS (2016)
A Comparative High-Throughput Screening Protocol to Identify Entry Inhibitors of Enveloped Viruses
Juan Wang et al.
JOURNAL OF BIOMOLECULAR SCREENING (2014)
Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
Hatem A. Elshabrawy et al.
PLOS ONE (2012)
Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses
Sheli R. Radoshitzky et al.
NATURE (2007)
A serological survey on neutralizing antibody titer of SARS convalescent sera
JS Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Occupancy and mechanism in anti body-mediated neutralization of animal viruses
PJ Klasse et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival
DMY Sze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
